الملخص الإنجليزي
Background. — The Coronavirus disease (Covid-19) 2019 pandemic had a serious impact on the
mental health of individuals globally. A lack of psychological well-being on the part of individ uals with chronic diseases might increase the risk of developing symptoms such as insomnia,
depression, and anxiety.
Objectives. — The aim of this study is to evaluate the prevalence of insomnia, depression, and
anxiety among patients with chronic disease during the Covid-19 pandemic in Oman.
Methods. — This is a web-based cross-sectional study conducted between June 2021 and
September 2021. Insomnia was assessed by using the Insomnia Severity Index (ISI), while depres sion and anxiety were measured using the Hospital Anxiety and Depression Scale (HADS).
Results. — Of the 922 chronic disease patients who participated, 77% (n = 710) reported insom nia, while the mean score for the ISI was11.38 (SD 5.82). Depression and anxiety were prevalent
among the participants with 47% and 63% respectively. The participants' mean with regard to the
sleep duration items was 7.04 (SD = 1.59) hours per night, whereas the mean in terms of sleep
latency was 38.18 minutes (SD = 31.81). Logistic regression analysis revealed that insomnia was
positively associated with depression and anxiety.
Conclusions. — This study demonstrated that chronic disease patients had a high prevalence
of insomnia during the Covid-19 pandemic. Psychological support is recommended in order to
help such patients reduce the level of insomnia. Furthermore, a routine assessment of levels of
insomnia, depression and anxiety is essential, in order to help identify appropriate intervention
and management measures.
